Veterinary Neurodegenerative Disease Diagnostics Market Size, Share, Trends, & Industry Analysis Report By Product (Consumables, Reagents, & Kits and Equipment & Instruments), By Test, By Animal Type, By Indication, By End Use, and By Region – Market Fore

The veterinary neurodegenerative disease diagnostics market size is expected to reach USD 805.79 million by 2034, according to a new study by Polaris Market Research. The report “Veterinary Neurodegenerative Disease Diagnostics Market Share, Size, Trends, Industry Analysis Report By Product (Consumables, Reagents & Kits and Equipment & Instruments), By Test, By Animal Type, By Indication, By End Use, and By Region; Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The veterinary neurodegenerative disease diagnostics is a specialized sector within the broader veterinary healthcare industry, focusing on the detection and management of neurodegenerative disorders in animals. Neurodegenerative diseases such as cognitive dysfunction syndrome (CDS) in dogs, feline dementia, and equine motor neuron disease are increasingly recognized as serious health concerns in aging pets and livestock. Early and accurate diagnosis is crucial for managing these conditions, improving animal welfare, and extending quality of life.

The market encompasses various diagnostic tools, including advanced imaging techniques, cerebrospinal fluid (CSF) analysis, gene therapy, and biomarker assessments. The growing awareness of neurological disorders in animals, coupled with advancements in veterinary diagnostics, is driving market expansion. Additionally, the rising trend of pet humanization, where pets are considered family members, is leading to increased spending on advanced veterinary care, further propelling demand for neurodegenerative disease diagnostics.

Veterinary Neurodegenerative Disease Diagnostics Market Report Highlights

In terms of product, the consumables, reagents & kits segment accounted for a major share in 2024 due to their essential role in early detection and accurate diagnosis of neurological disorders in animals.

Based on test, the imaging segment dominated the market share in 2024 due to its critical role in identifying abnormalities in the brain and spinal cord of animals.

In terms of animal type, the companion segment held the largest share in 2024, owing to the rising prevalence of neurological disorders in aging pets, particularly dogs and cats.

The North America veterinary neurodegenerative disease diagnostics market accounted for the largest share in 2024 due to the rising prevalence of neurodegenerative disorders in pets, particularly in dog and cat populations.

The market in Europe is projected to grow at a robust pace in the coming years, owing to the increasing geriatric pet population and growing awareness of neurological disorders.

The market in Asia Pacific is projected to hold a substantial share in 2034 due to rising pet adoption, increasing disposable income, and improving veterinary healthcare infrastructure.

A few global key market players include ACUVET BIOTECH; Antech Diagnostics, Inc.; Avacta Animal Health Limited; Heska Corporation; IDEXX Laboratories, Inc.; Life Diagnostics; Merck & Co., Inc.; Mercodia AB; MI:RNA Diagnostics Ltd.; Virbac; and Zoetis.

Polaris Market Research has segmented the veterinary neurodegenerative disease diagnostics market report on the basis of product, test, animal type, indication, end use, and region:

By Product Outlook (Revenue, USD Million, 2020–2034)

Consumables, Reagents & Kits

Equipment & Instruments

By Test Outlook (Revenue, USD Million, 2020–2034)

Imaging

MRI (Magnetic Resonance Imaging)

CT (Computed Tomography)

Others

Biomarker Diagnostic Tests

CSF (Cerebrospinal Fluid) biomarkers

Blood-based biomarkers

Others

Others

By Animal Type Outlook (Revenue, USD Million, 2020–2034)

Livestock

Sheep

Cattle

Others

Companion

Canine

Feline

Equine

Others

By Indication Outlook (Revenue, USD Million, 2020–2034)

Cognitive Dysfunction

Cerebellar Abiotrophy

Spongiform Encephalopathies

Others

By End Use Outlook (Revenue, USD Million, 2020–2034

Veterinary Hospitals and Clinics

Veterinary Diagnostic Laboratories

Others

By Regional Outlook (Revenue, USD Million, 2020–2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America